How Americans spent $6.2 billion to develop overpriced diabetes and weight-loss drugs.
Pharma
U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could bankrupt the U.S. health care system.
While proponents claim direct-to-consumer drug ads educate consumers, critics say that mass-market misinformation is costing patients and taxpayers alike.
As corporate pharmacy middlemen slash reimbursement fees to independent drugstores, local Illinois pharmacists push for legislative change.